Biotech · Private company
Millennium: The Takeda Oncology Company
Track this companyFree. Adds Millennium: The Takeda Oncology Company to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials3
- Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic MalignanciesPHASE2 · COMPLETED · started Mar 10, 2017ClinicalTrials.gov NCT03082677 · fetched Nov 12, 2026
- Study of Ixazomib and Erlotinib in Solid TumorsPHASE1 · COMPLETED · started Mar 6, 2017ClinicalTrials.gov NCT02942095 · fetched Nov 12, 2026
- Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate CancerPHASE1_PHASE2 · COMPLETED · started Aug 14, 2013ClinicalTrials.gov NCT01848067 · fetched Nov 12, 2026